Qing Yao is a Principal Scientist II at Gilead Sciences, where they lead a team focused on determining macromolecular structures to aid in developing innovative therapeutics. Previously, they contributed significantly to Amgen as a Scientist and Group Leader, overseeing Cryo-EM operations and user training. Qing has over ten years of experience in biochemistry and structural biology, including Cryo-EM and X-ray crystallography, and has a strong publication record with nine first-author papers in high-profile journals. They earned a Ph.D. in Biochemistry and Molecular Biology from the National Institute of Biological Sciences in Beijing, where they conducted groundbreaking research on bacterial toxins.
This person is not in the org chart
This person is not in any teams
This person is not in any offices